Jonathan Shamash

5.7k total citations
141 papers, 3.1k citations indexed

About

Jonathan Shamash is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Jonathan Shamash has authored 141 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pulmonary and Respiratory Medicine, 72 papers in Surgery and 34 papers in Molecular Biology. Recurrent topics in Jonathan Shamash's work include Testicular diseases and treatments (63 papers), Sarcoma Diagnosis and Treatment (26 papers) and Neuroblastoma Research and Treatments (25 papers). Jonathan Shamash is often cited by papers focused on Testicular diseases and treatments (63 papers), Sarcoma Diagnosis and Treatment (26 papers) and Neuroblastoma Research and Treatments (25 papers). Jonathan Shamash collaborates with scholars based in United Kingdom, United States and Denmark. Jonathan Shamash's co-authors include Thomas Powles, Daniel M. Berney, R.T.D. Oliver, Jeremy Steele, Robin Rudd, Justin Stebbing, Marie T. Evans, Peter Wilson, Henrik Møller and Dean A. Fennell and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jonathan Shamash

137 papers receiving 3.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jonathan Shamash	1.5k	981	937	698	425	141	3.1k
Fariba Navid	1.3k 0.9×	896 0.9×	416 0.4×	686 1.0×	298 0.7×	104	2.8k
Stefano Serra	615 0.4×	1.4k 1.5×	1.1k 1.1×	666 1.0×	420 1.0×	121	2.8k
Shaobo Zhang	1.6k 1.1×	511 0.5×	1.7k 1.8×	1.6k 2.3×	681 1.6×	100	3.7k
Avishay Sella	1.8k 1.2×	1.2k 1.2×	1.8k 1.9×	860 1.2×	517 1.2×	105	3.6k
Pamela D. Unger	1.1k 0.7×	478 0.5×	992 1.1×	602 0.9×	262 0.6×	138	3.1k
Shi‐Ming Tu	1.8k 1.2×	1.4k 1.5×	996 1.1×	1.2k 1.7×	572 1.3×	95	3.6k
Eun Kyung Hong	1.0k 0.7×	1.0k 1.0×	979 1.0×	524 0.8×	355 0.8×	127	2.6k
Pinuccia Faviana	497 0.3×	1.0k 1.1×	693 0.7×	956 1.4×	297 0.7×	85	3.4k
Danai Daliani	1.3k 0.9×	1.1k 1.1×	805 0.9×	900 1.3×	418 1.0×	53	2.9k
Francesca Sanguedolce	744 0.5×	547 0.6×	701 0.7×	700 1.0×	338 0.8×	167	2.3k

Countries citing papers authored by Jonathan Shamash

Since Specialization

Citations

This map shows the geographic impact of Jonathan Shamash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Shamash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Shamash more than expected).

Fields of papers citing papers by Jonathan Shamash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Shamash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Shamash. The network helps show where Jonathan Shamash may publish in the future.

Co-authorship network of co-authors of Jonathan Shamash

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Shamash. A scholar is included among the top collaborators of Jonathan Shamash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Shamash. Jonathan Shamash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dee, Edward Christopher, Kenrick Ng, Gloryanne Aidoo-Micah, et al.. (2024). Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards. Nature Reviews Urology. 22(4). 223–234. 4 indexed citations

MacDonald, Nicola, Michelle Lockley, Rowan Miller, et al.. (2022). Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 271. 138–144. 5 indexed citations

Lloyd, Paul, Anne Hong, Marc A. Furrer, et al.. (2021). A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections. World Journal of Urology. 40(1). 119–126. 22 indexed citations

Alifrangis, Constantine, Olivia Lucas, Sarah Benafif, et al.. (2020). Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery. European Urology Focus. 7(4). 835–842. 7 indexed citations

Scandura, Glenda, Thomas Wagner, Luis Beltrán, et al.. (2020). Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?. Modern Pathology. 34(4). 834–841. 3 indexed citations

Shamash, Jonathan, Rizwan Syed, Shah‐Jalal Sarker, et al.. (2019). A phase II study of carboplatin AUC-10 guided by positron emission tomography–defined metabolic response in metastatic seminoma. European Journal of Cancer. 115. 128–135. 8 indexed citations

Xu, Lei, Xueying Mao, Tianyu Guo, et al.. (2017). The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis. Clinical Cancer Research. 23(17). 5112–5122. 54 indexed citations

Shamash, Jonathan, Shah‐Jalal Sarker, Robert Huddart, et al.. (2017). A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3). Annals of Oncology. 28(6). 1333–1338. 15 indexed citations

Powles, Thomas, Irfan Kayani, Kevin Sharpe, et al.. (2013). A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer. Annals of Oncology. 24(8). 2098–2103. 37 indexed citations

10.

Kayani, Irfan, Norbert Avril, Jamshed Bomanji, et al.. (2011). Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer. Clinical Cancer Research. 17(18). 6021–6028. 84 indexed citations

11.

Gillessen, Silke, Thomas Powles, Louise Lim, Peter Wilson, & Jonathan Shamash. (2010). Low-dose induction chemotherapy with Baby-BOP in patients with metastatic germ-cell tumours does not compromise outcome: a single-centre experience. Annals of Oncology. 21(8). 1589–1593. 9 indexed citations

12.

Powles, Thomas, S. Chowdhury, Jonathan Shamash, et al.. (2010). Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinib. Annals of Oncology. 22(4). 815–820. 1 indexed citations

13.

Intermesoli, Tamara, Jonathan Shamash, A. Z. S. Rohatiner, et al.. (2009). Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy. British Journal of Haematology. 147(3). 408–410. 1 indexed citations

14.

Powles, Thomas, David Robinson, Justin Stebbing, et al.. (2008). Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection. Journal of Clinical Oncology. 27(6). 884–890. 269 indexed citations

15.

Hughes, Simon, Aisha Miah, Shahreen Ahmad, et al.. (2008). A Brief Report on the Safety Study of Induction Chemotherapy Followed by Synchronous Radiotherapy and Cetuximab in Stage III Non-small Cell Lung Cancer (NSCLC): SCRATCH Study. Journal of Thoracic Oncology. 3(6). 648–651. 52 indexed citations

16.

Williams, M.V., David E. Neal, J. Ong, et al.. (2008). Stage migration and pilot studies of reduced chemotherapy supported by positron‐emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumour. British Journal of Urology. 101(5). 570–574. 1 indexed citations

17.

Hughes, Simon, Aisha Miah, Shahreen Ahmad, et al.. (2007). P2-184: Safety study of induction chemotherapy followed by Synchronous Radiotherapy (RT) and cetuximab in stage III non-small cell lung cancer (NSCLC): SCRATCH study (Cohort I). Journal of Thoracic Oncology. 2(8). S642–S643. 1 indexed citations

18.

Powles, Thomas, David Robinson, Jonathan Shamash, et al.. (2007). The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Annals of Oncology. 19(3). 443–447. 85 indexed citations

19.

Shamash, Jonathan, Tom Powles, Peter Wilson, et al.. (2007). A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours. Annals of Oncology. 18(5). 925–930. 22 indexed citations

20.

Shamash, Jonathan, Siow Ming Lee, John Radford, et al.. (2000). Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study. Annals of Oncology. 11(6). 715–719. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact